生物製品外包市场规模 - 按产品（抗体、重组蛋白、疫苗）、服务（细胞和製程开发、分析测试）、来源（哺乳动物、微生物）、应用、最终用户、全球预测，2023 - 2032 年

由于生物製药公司与外包合作伙伴之间的研发合作日益受到重视，生物製品外包市场规模预计在 2023 年至 2032 年期间以 14.1% 的复合年增长率扩大。生物药物开发和生产的复杂性不断增加，加上合作关係，使得专业知识、技术和资源的共享成为可能，同时促进高效、及时地交付高品质产品。此类措施正在促进创新、加快产品开发时间并提高成本效益，以满足​​生物製药领域不断变化的需求。

此外，随着大量公司努力优化研发工作，该产业将在预测期内获得显着的发展动能。举个例子，2023年10月，生物製药开发商Tanvex BioPharma USA Inc.推出了Tanvex CDMO，为生物製药行业提供全面的生物製剂合约开发和生产服务。

整个生物製品外包产业根据产品、服务、来源、应用、最终用户和地区进行细分。

在产品方面，由于对先进疫苗开发和生产服务的需求不断增加，预计2023年至2032年疫苗领域的市场规模将出现高需求。全球对预防性医疗保健的日益关注以及传染病发病率的不断增加，对高效、可扩展的疫苗生产解决方案的需求不断增加。此外，生物技术的快速进步和对个人化医疗的日益重视将进一步推动该领域的成长。

预计到 2032 年，生物製品外包产业将受到血液相关产品开发应用领域的巨大吸引力。血液疾病的广泛流行和对先进治疗解决方案不断增长的需求正在推动对专业生物製品外包服务的需求。此外，对个人化医疗的日益重视以及针对各种血液相关疾病的标靶生物疗法的开发也将有助于越来越多地采用外包生物製剂服务。

从地区来看，在该地区製药和生技产业不断扩张的推动下，亚太地区生物製品外包产业预计将在 2023 年至 2032 年期间实现强劲成长。对先进生物疗法的需求激增以及对个人化医疗的日益关注正在推动对专业外包服务的需求。此外，具有成本效益的製造能力和熟练的劳动力正在吸引全球生物製药公司寻求高效和高品质的外包解决方案，进一步增强了该地区的行业前景。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：生物製剂外包产业洞察

• 行业细分
• 产业格局，2018 - 2032
• 产业影响力
  • 成长动力
    • 生物製品製造日益复杂，导致外包服务增加
    • CRO 和 CMO 提供的成本效益和效率
    • CRO和CMO提供的技术优势
    • 专利到期和生物製品需求增加
    • CDMO 增加对先进製造技术的投资
    • 提高监管合规性和品质保证
  • 产业陷阱与挑战
    • 不同地区的监管要求不同
    • 缺乏持续创新来平衡技术能力与成本
    • 内部专业知识流失的可能性可能限制生物製品外包
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
  • 我们
  • 加拿大
  • 欧洲
• 技术景观
• 产业生态系统
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
  • Merck & Co. Inc
  • AbbVie Inc
  • Thermo Fischer Scientific, Inc.
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 公司市占率分析
• 战略仪表板

第 5 章：生物製剂外包市场：依产品分类，2018 - 2032

• 主要动向：按产品
• 抗体
  • 单株抗体
  • 多株抗体抗体
  • 抗体药物偶联物
• 疫苗
• 细胞和基因疗法
• 重组蛋白
• 血液和血液製品
• 其他生物製剂

第 6 章：生物製品外包市场：依服务分类，2018 - 2032

• 主要动力向：按服务
• 分析测试
• 製程开发
• 细胞发育
• cGMP 製造
• 其他服务

第 7 章：生物製品外包市场：依来源划分，2018 年 - 2032 年

• 主要动向：按来源
• 哺乳动物
  • 动物
  • 人类
• 微生物

第 8 章：生物製剂外包市场：按应用，2018 - 2032

• 主要动向：按应用
• 肿瘤学
• 免疫系统疾病
• 传染性疾病
• 疫苗开发
• 细胞和基因治疗
• 血液相关产品开发
• 干细胞研究
• 其他应用

第 9 章：生物製剂外包市场：依最终用户划分，2018 年 - 2032 年

• 主要动向：由最终用户
• 製药和生物製药公司
• 生技公司

第 10 章：生物製剂外包市场：按地区划分，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 瑞士
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 11 章：公司简介

• AbbVie Inc.
• Thermo Fischer Scientific Inc.
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• Lonza Group AG
• Catalent, Inc
• Wacker Chemie AG (Wacker Biotech GmbH Plc.)
• WuXi AppTec Co., Ltd.
• Samsung Biologics Co., Ltd.
• AGC Biologics
• Scorpius BioManufacturing

Biologics Outsourcing Market size is poised to expand at 14.1% CAGR from 2023-2032 driven by the increasing focus on R&D collaborations between biopharmaceutical companies and outsourcing partners. The rising complexities of biological drug development and production along with collaborative partnerships are enabling the sharing of specialized expertise, technologies, and resources while facilitating the efficient and timely delivery of high-quality products. Such initiatives are fostering innovations, accelerating product development timelines, and enhancing cost-effectiveness for meeting the evolving demands of the biopharmaceutical field.

Moreover, with the large number of companies striving to optimize their R&D efforts, the industry will gain significant momentum in the forecast period. To cite an instance, in October 2023, biopharmaceutical developer Tanvex BioPharma USA Inc. launched Tanvex CDMO to provide comprehensive biologic contract development and production services to the biopharmaceutical sector.

The overall biologics outsourcing industry is segmented based on product, service, source, application, end-user, and region.

With respect to product, the market size from the vaccines segment is anticipated to witness high demand from 2023-2032 driven by the increasing demand for advanced vaccine development and production services. The rising focus on preventive healthcare worldwide and the increasing incidence of infectious diseases is escalating the demand for efficient and scalable vaccine manufacturing solutions. Moreover, the rapid advancements in biotechnology and the growing emphasis on personalized medicine will further boost the segment growth.

Biologics outsourcing industry is anticipated to foresee immense traction from the blood-related product development application segment through 2032. The widespread prevalence of blood disorders and the growing demand for advanced therapeutic solutions are propelling the need for specialized biologics outsourcing services. Moreover, the growing emphasis on personalized medicine and the development of targeted biologic therapies for various blood-related conditions will also contribute to the increasing adoption of outsourced biologics services.

Regionally, the Asia Pacific biologics outsourcing industry is estimated to record robust growth from 2023-2032 fueled by the expanding pharmaceutical and biotechnology sectors in the region. The surging demand for advanced biological therapies and the rising focus on personalized medicine is fueling the need for specialized outsourcing services. Additionally, the presence of cost-effective manufacturing capabilities and skilled workforce is attracting global biopharmaceutical several companies seeking efficient and high-quality outsourcing solutions, further augmenting the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Biologics outsourcing industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product trends
  • 2.1.4 Service trends
  • 2.1.5 Source trends
  • 2.1.6 Application trends
  • 2.1.7 End-user trends

Chapter 3 Biologics Outsourcing Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032 (USD Million)
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Growing complexity of biologics manufacturing, leading to increased outsourcing services
    • 3.3.1.2 Cost-effectiveness and efficiency offered by CROs and CMOs
    • 3.3.1.3 Technological advantages offered by CROs and CMOs
    • 3.3.1.4 Patent expiry and increasing demand for biologics
    • 3.3.1.5 Increasing investments in advanced manufacturing technologies by CDMOs
    • 3.3.1.6 Increasing regulatory compliance and quality assurance
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Varying regulatory requirements across regions
    • 3.3.2.2 Lack of constant innovation to balance technological capabilities against costs
    • 3.3.2.3 Potential for loss of in-house expertise may limit biologics outsourcing
• 3.4 Growth potential analysis
  • 3.4.1 By product
  • 3.4.2 By service
  • 3.4.3 By source
  • 3.4.4 By application
  • 3.4.5 By end-user
• 3.5 COVID- 19 impact analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Canada
  • 3.6.3 Europe
• 3.7 Technology landscape
• 3.8 Industry ecosystem
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Merck & Co. Inc
  • 4.1.2 AbbVie Inc
  • 4.1.3 Thermo Fischer Scientific, Inc.
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Company market share analysis, 2022
• 4.6 Strategy dashboard, 2022

Chapter 5 Biologics Outsourcing Market, By Product, 2018 - 2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Antibodies
  • 5.2.1 Monoclonal antibodies
  • 5.2.2 Polyclonal antibodies
  • 5.2.3 Antibody drug conjugates
• 5.3 Vaccines
• 5.4 Cell and gene therapeutics
• 5.5 Recombinant proteins
• 5.6 Blood and blood products
• 5.7 Other biologics

Chapter 6 Biologics Outsourcing Market, By Service, 2018 - 2032 (USD Million)

• 6.1 Key trends, by service
• 6.2 Analytical testing
• 6.3 Process development
• 6.4 Cell development
• 6.5 cGMP manufacturing
• 6.6 Other services

Chapter 7 Biologics Outsourcing Market, By Source, 2018 - 2032 (USD Million)

• 7.1 Key trends, by source
• 7.2 Mammalian
  • 7.2.1 Animals
  • 7.2.2 Human
• 7.3 Microorganisms

Chapter 8 Biologics Outsourcing Market, By Application, 2018 - 2032 (USD Million)

• 8.1 Key trends, by application
• 8.2 Oncology
• 8.3 Immunological disorders
• 8.4 Infectious diseases
• 8.5 Vaccine development
• 8.6 Cell and gene therapy
• 8.7 Blood related product development
• 8.8 Stem cell research
• 8.9 Other applications

Chapter 9 Biologics Outsourcing Market, By End-user, 2018 - 2032 (USD Million)

• 9.1 Key trends, by end-user
• 9.2 Pharmaceutical and biopharmaceutical companies
• 9.3 Biotechnological companies

Chapter 10 Biologics Outsourcing Market, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Switzerland
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 AbbVie Inc.
• 11.2 Thermo Fischer Scientific Inc.
• 11.3 Boehringer Ingelheim International GmbH
• 11.4 Merck & Co., Inc.
• 11.5 Lonza Group AG
• 11.6 Catalent, Inc
• 11.7 Wacker Chemie AG (Wacker Biotech GmbH Plc.)
• 11.8 WuXi AppTec Co., Ltd.
• 11.9 Samsung Biologics Co., Ltd.
• 11.10 AGC Biologics
• 11.11 Scorpius BioManufacturing

Data Tables

• TABLE 1 Market revenue, by product (2022)
• TABLE 2 Market revenue, by service (2022)
• TABLE 3 Market revenue, by source (2022)
• TABLE 4 Market revenue, by application (2022)
• TABLE 5 Market revenue, by end-user (2022)
• TABLE 6 Market share, by region (2022)
• TABLE 7 Biologics outsourcing market size, by region, 2018 - 2024 (USD Million)
• TABLE 8 Biologics outsourcing market size, by region, 2025 - 2032 (USD Million)
• TABLE 9 Biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 10 Biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 11 Biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 12 Biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 13 Biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 14 Biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 15 Biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 16 Biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 17 Biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 18 Biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 19 Industry impact forces
• TABLE 20 Competitive benchmarking of major market players
• TABLE 21 Competitive positioning matrix: Classification criteria
• TABLE 22 Antibodies market size, 2018 - 2024 (USD Million)
• TABLE 23 Antibodies market size, 2025 - 2032 (USD Million)
• TABLE 24 Monoclonal antibodies market size, 2018 - 2024 (USD Million)
• TABLE 25 Monoclonal antibodies market size, 2025 - 2032 (USD Million)
• TABLE 26 Polyclonal antibodies market size, 2018 - 2024 (USD Million)
• TABLE 27 Polyclonal antibodies market size, 2025 - 2032 (USD Million)
• TABLE 28 Antibody drug conjugates market size, 2018 - 2024 (USD Million)
• TABLE 29 Antibody drug conjugates market size, 2025 - 2032 (USD Million)
• TABLE 30 Recombinant proteins market size, 2018 - 2024 (USD Million)
• TABLE 31 Recombinant proteins market size, 2025 - 2032 (USD Million)
• TABLE 32 Vaccines market size, 2018 - 2024 (USD Million)
• TABLE 33 Vaccines market size, 2025 - 2032 (USD Million)
• TABLE 34 Cell and gene therapeutics market size, 2018 - 2024 (USD Million)
• TABLE 35 Cell and gene therapeutics market size, 2025 - 2032 (USD Million)
• TABLE 36 Blood and blood products market size, 2018 - 2024 (USD Million)
• TABLE 37 Blood and blood products market size, 2025 - 2032 (USD Million)
• TABLE 38 Other biologics market size, 2018 - 2024 (USD Million)
• TABLE 39 Other biologics market size, 2025 - 2032 (USD Million)
• TABLE 40 Cell development market size, 2018 - 2024 (USD Million)
• TABLE 41 Cell development market size, 2025 - 2032 (USD Million)
• TABLE 42 Process development market size, 2018 - 2024 (USD Million)
• TABLE 43 Process development market size, 2025 - 2032 (USD Million)
• TABLE 44 Analytical testing market size, 2018 - 2024 (USD Million)
• TABLE 45 Analytical testing market size, 2025 - 2032 (USD Million)
• TABLE 46 cGMP manufacturing market size, 2018 - 2024 (USD Million)
• TABLE 47 cGMP manufacturing market size, 2025 - 2032 (USD Million)
• TABLE 48 Other services market size, 2018 - 2024 (USD Million)
• TABLE 49 Other services market size, 2025 - 2032 (USD Million)
• TABLE 50 Mammalian market size, 2018 - 2024 (USD Million)
• TABLE 51 Mammalian market size, 2025 - 2032 (USD Million)
• TABLE 52 Human market size, 2018 - 2024 (USD Million)
• TABLE 53 Human market size, 2025 - 2032 (USD Million)
• TABLE 54 Animals market size, 2018 - 2024 (USD Million)
• TABLE 55 Animals market size, 2025 - 2032 (USD Million)
• TABLE 56 Microorganisms market size, 2018 - 2024 (USD Million)
• TABLE 57 Microorganisms market size, 2025 - 2032 (USD Million)
• TABLE 58 Infectious diseases market size, 2018 - 2024 (USD Million)
• TABLE 59 Infectious diseases market size, 2025 - 2032 (USD Million)
• TABLE 60 Immunological disorders market size, 2018 - 2024 (USD Million)
• TABLE 61 Immunological disorders market size, 2025 - 2032 (USD Million)
• TABLE 62 Oncology market size, 2018 - 2024 (USD Million)
• TABLE 63 Oncology market size, 2025 - 2032 (USD Million)
• TABLE 64 Cell and gene therapy market size, 2018 - 2024 (USD Million)
• TABLE 65 Cell and gene therapy market size, 2025 - 2032 (USD Million)
• TABLE 66 Vaccine development market size, 2018 - 2024 (USD Million)
• TABLE 67 Vaccine development market size, 2025 - 2032 (USD Million)
• TABLE 68 Blood related product development market size, 2018 - 2024 (USD Million)
• TABLE 69 Blood related product development market size, 2025 - 2032 (USD Million)
• TABLE 70 Stem cell research market size, 2018 - 2024 (USD Million)
• TABLE 71 Stem cell research market size, 2025 - 2032 (USD Million)
• TABLE 72 Other applications market size, 2018 - 2024 (USD Million)
• TABLE 73 Other applications market size, 2025 - 2032 (USD Million)
• TABLE 74 Pharmaceutical and biopharmaceutical companies market size, 2018 - 2024 (USD Million)
• TABLE 75 Pharmaceutical and biopharmaceutical companies market size, 2025 - 2032 (USD Million)
• TABLE 76 Biotechnological companies market size, 2018 - 2024 (USD Million)
• TABLE 77 Biotechnological companies market size, 2025 - 2032 (USD Million)
• TABLE 78 North America biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 79 North America biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 80 North America biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 81 North America biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 82 North America biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 83 North America biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 84 North America biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 85 North America biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 86 North America biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 87 North America biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 88 North America biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 89 North America biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 90 North America biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 91 North America biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 92 North America biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 93 North America biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 94 U.S. biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 95 U.S. biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 96 U.S. biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 97 U.S. biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 98 U.S. biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 99 U.S. biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 100 U.S. biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 101 U.S. biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 102 U.S. biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 103 U.S. biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 104 U.S. biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 105 U.S. biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 106 U.S. biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 107 U.S. biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 108 Canada biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 109 Canada biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 110 Canada biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 111 Canada biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 112 Canada biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 113 Canada biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 114 Canada biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 115 Canada biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 116 Canada biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 117 Canada biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 118 Canada biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 119 Canada biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 120 Canada biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 121 Canada biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 122 Europe biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 123 Europe biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 124 Europe biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 125 Europe biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 126 Europe biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 127 Europe biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 128 Europe biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 129 Europe biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 130 Europe biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 131 Europe biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 132 Europe biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 133 Europe biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 134 Europe biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 135 Europe biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 136 Europe biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 137 Europe biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 138 Germany biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 139 Germany biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 140 Germany biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 141 Germany biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 142 Germany biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 143 Germany biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 144 Germany biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 145 Germany biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 146 Germany biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 147 Germany biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 148 Germany biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 149 Germany biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 150 Germany biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 151 Germany biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 152 UK biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 153 UK biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 154 UK biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 155 UK biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 156 UK biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 157 UK biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 158 UK biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 159 UK biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 160 UK biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 161 UK biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 162 UK biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 163 UK biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 164 UK biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 165 UK biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 166 France biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 167 France biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 168 France biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 169 France biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 170 France biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 171 France biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 172 France biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 173 France biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 174 France biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 175 France biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 176 France biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 177 France biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 178 France biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 179 France biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 180 Italy biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 181 Italy biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 182 Italy biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 183 Italy biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 184 Italy biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 185 Italy biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 186 Italy biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 187 Italy biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 188 Italy biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 189 Italy biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 190 Italy biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 191 Italy biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 192 Italy biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 193 Italy biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 194 Spain biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 195 Spain biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 196 Spain biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 197 Spain biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 198 Spain biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 199 Spain biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 200 Spain biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 201 Spain biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 202 Spain biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 203 Spain biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 204 Spain biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 205 Spain biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 206 Spain biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 207 Spain biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 208 Switzerland biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 209 Switzerland biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 210 Switzerland biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 211 Switzerland biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 212 Switzerland biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 213 Switzerland biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 214 Switzerland biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 215 Switzerland biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 216 Switzerland biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 217 Switzerland biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 218 Switzerland biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 219 Switzerland biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 220 Switzerland biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 221 Switzerland biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 222 Rest of Europe biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 223 Rest of Europe biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 224 Rest of Europe biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 225 Rest of Europe biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 226 Rest of Europe biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 227 Rest of Europe biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 228 Rest of Europe biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 229 Rest of Europe biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 230 Rest of Europe biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 231 Rest of Europe biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 232 Rest of Europe biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 233 Rest of Europe biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 234 Rest of Europe biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 235 Rest of Europe biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 236 Asia Pacific biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 237 Asia Pacific biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 238 Asia Pacific biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 239 Asia Pacific biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 240 Asia Pacific biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 241 Asia Pacific biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 242 Asia Pacific biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 243 Asia Pacific biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 244 Asia Pacific biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 245 Asia Pacific biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 246 Asia Pacific biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 247 Asia Pacific biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 248 Asia Pacific biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 249 Asia Pacific biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 250 Asia Pacific biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 251 Asia Pacific biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 252 Japan biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 253 Japan biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 254 Japan biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 255 Japan biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 256 Japan biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 257 Japan biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 258 Japan biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 259 Japan biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 260 Japan biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 261 Japan biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 262 Japan biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 263 Japan biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 264 Japan biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 265 Japan biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 266 China biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 267 China biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 268 China biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 269 China biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 270 China biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 271 China biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 272 China biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 273 China biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 274 China biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 275 China biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 276 China biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 277 China biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 278 China biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 279 China biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 280 India biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 281 India biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 282 India biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 283 India biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 284 India biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 285 India biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 286 India biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 287 India biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 288 India biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 289 India biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 290 India biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 291 India biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 292 India biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 293 India biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 294 Australia biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 295 Australia biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 296 Australia biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 297 Australia biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 298 Australia biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 299 Australia biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 300 Australia biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 301 Australia biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 302 Australia biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 303 Australia biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 304 Australia biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 305 Australia biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 306 Australia biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 307 Australia biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 308 Rest of Asia Pacific biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 309 Rest of Asia Pacific biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 310 Rest of Asia Pacific biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 311 Rest of Asia Pacific biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 312 Rest of Asia Pacific biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 313 Rest of Asia Pacific biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 314 Rest of Asia Pacific biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 315 Rest of Asia Pacific biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 316 Rest of Asia Pacific biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 317 Rest of Asia Pacific biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 318 Rest of Asia Pacific biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 319 Rest of Asia Pacific biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 320 Rest of Asia Pacific biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 321 Rest of Asia Pacific biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 322 Latin America biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 323 Latin America biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 324 Latin America biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 325 Latin America biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 326 Latin America biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 327 Latin America biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 328 Latin America biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 329 Latin America biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 330 Latin America biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 331 Latin America biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 332 Latin America biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 333 Latin America biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 334 Latin America biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 335 Latin America biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 336 Latin America biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 337 Latin America biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 338 Brazil biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 339 Brazil biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 340 Brazil biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 341 Brazil biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 342 Brazil biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 343 Brazil biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 344 Brazil biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 345 Brazil biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 346 Brazil biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 347 Brazil biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 348 Brazil biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 349 Brazil biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 350 Brazil biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 351 Brazil biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 352 Mexico biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 353 Mexico biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 354 Mexico biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 355 Mexico biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 356 Mexico biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 357 Mexico biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 358 Mexico biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 359 Mexico biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 360 Mexico biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 361 Mexico biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 362 Mexico biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 363 Mexico biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 364 Mexico biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 365 Mexico biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 366 Rest of Latin America biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 367 Rest of Latin America biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 368 Rest of Latin America biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 369 Rest of Latin America biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 370 Rest of Latin America biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 371 Rest of Latin America biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 372 Rest of Latin America biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 373 Rest of Latin America biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 374 Rest of Latin America biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 375 Rest of Latin America biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 376 Rest of Latin America biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 377 Rest of Latin America biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 378 Rest of Latin America biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 379 Rest of Latin America biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 380 Middle East & Africa biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 381 Middle East & Africa biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 382 Middle East & Africa biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 383 Middle East & Africa biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 384 Middle East & Africa biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 385 Middle East & Africa biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 386 Middle East & Africa biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 387 Middle East & Africa biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 388 Middle East & Africa biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 389 Middle East & Africa biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 390 Middle East & Africa biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 391 Middle East & Africa biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 392 Middle East & Africa biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 393 Middle East & Africa biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 394 Middle East & Africa biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 395 Middle East & Africa biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 396 South Africa biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 397 South Africa biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 398 South Africa biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 399 South Africa biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 400 South Africa biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 401 South Africa biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 402 South Africa biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 403 South Africa biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 404 South Africa biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 405 South Africa biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 406 South Africa biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 407 South Africa biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 408 South Africa biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 409 South Africa biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 410 Saudi Arabia biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 411 Saudi Arabia biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 412 Saudi Arabia biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 413 Saudi Arabia biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 414 Saudi Arabia biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 415 Saudi Arabia biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 416 Saudi Arabia biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 417 Saudi Arabia biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 418 Saudi Arabia biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 419 Saudi Arabia biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 420 Saudi Arabia biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 421 Saudi Arabia biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 422 Saudi Arabia biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 423 Saudi Arabia biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 424 Rest of Middle East & Africa biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 425 Rest of Middle East & Africa biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 426 Rest of Middle East & Africa biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 427 Rest of Middle East & Africa biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 428 Rest of Middle East & Africa biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 429 Rest of Middle East & Africa biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 430 Rest of Middle East & Africa biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 431 Rest of Middle East & Africa biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 432 Rest of Middle East & Africa biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 433 Rest of Middle East & Africa biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 434 Rest of Middle East & Africa biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 435 Rest of Middle East & Africa biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 436 Rest of Middle East & Africa biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 437 Rest of Middle East & Africa biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Biologics outsourcing industry 360 degree synopsis, 2018 - 2032
• FIG 7 Industry segmentation
• FIG 8 Industry landscape, 2018 - 2032 (USD Million)
• FIG 9 Growth potential analysis, by product
• FIG 10 Growth potential analysis, by service
• FIG 11 Growth potential analysis, by source
• FIG 12 Growth potential analysis, by application
• FIG 13 Growth potential analysis, by end-user
• FIG 14 Industry ecosystem
• FIG 15 Porter's analysis
• FIG 16 PESTEL analysis
• FIG 17 Company matrix analysis, 2022
• FIG 18 Competitive analysis of major market players
• FIG 19 Competitive positioning matrix, 2022
• FIG 20 Company market share analysis, 2022
• FIG 21 Strategy dashboard, 2022